These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 33414160)

  • 1. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    Shi Y; Shi J; Sun L; Tan Y; Wang G; Guo F; Hu G; Fu Y; Fu ZF; Xiao S; Peng G
    J Virol; 2021 Mar; 95(7):. PubMed ID: 33414160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Novel Neutralizing Epitope on the N-Terminal Domain of the Human Coronavirus 229E Spike Protein.
    Shi J; Shi Y; Xiu R; Wang G; Liang R; Jiao Y; Shen Z; Zhu C; Peng G
    J Virol; 2022 Feb; 96(4):e0195521. PubMed ID: 34908442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.
    Adami FL; de Castro MV; Almeida BDS; Daher IP; Yamamoto MM; Souza Santos K; Zatz M; Naslavsky MS; Rosa DS; Cunha-Neto E; de Oliveira VL; Kalil J; Boscardin SB
    Front Immunol; 2024; 15():1396603. PubMed ID: 38846944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
    Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
    Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen.
    Wang X; Sun L; Liu Z; Xing L; Zhu Y; Xu W; Xia S; Lu L; Jiang S
    Emerg Microbes Infect; 2023 Dec; 12(2):2244084. PubMed ID: 37534910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
    Tanunliong G; Liu AC; Kaweski S; Irvine M; Reyes RC; Purych D; Krajden M; Morshed M; Sekirov I; Gantt S; Skowronski DM; Jassem AN
    Front Immunol; 2022; 13():836449. PubMed ID: 35401521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study.
    Yu W; Wu X; Ren J; Zhang X; Wang Y; Li C; Xu W; Li J; Li G; Zheng W; Liao H; Yuan X
    Comb Chem High Throughput Screen; 2021; 24(7):1069-1082. PubMed ID: 33106140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.
    Liu D; Chen C; Chen D; Zhu A; Li F; Zhuang Z; Mok CKP; Dai J; Li X; Jin Y; Chen Z; Sun J; Wang Y; Li Y; Zhang Y; Wen L; Zhang Z; Zhuo J; Wang J; Ran W; Wang D; Zhang S; Tang Y; Li S; Lai X; Wei P; Yuan J; Chen F; Huang S; Sun F; Qian Z; Tan W; Zhao J; Peiris M; Zhao J
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2202820120. PubMed ID: 36652473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein.
    Xiang J; Su J; Lan Q; Zhao W; Zhou Y; Xu Y; Niu J; Xia S; Qi Q; Sidhu S; Lu L; Miersch S; Yang B
    Commun Biol; 2022 Nov; 5(1):1179. PubMed ID: 36333470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes.
    Song X; Shi Y; Ding W; Niu T; Sun L; Tan Y; Chen Y; Shi J; Xiong Q; Huang X; Xiao S; Zhu Y; Cheng C; Fu ZF; Liu ZJ; Peng G
    Nat Commun; 2021 Jan; 12(1):141. PubMed ID: 33420048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.
    Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
    Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
    Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolutionary dynamics of endemic human coronaviruses.
    Jo WK; Drosten C; Drexler JF
    Virus Evol; 2021 Jan; 7(1):veab020. PubMed ID: 33768964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.